Company Filing History:
Years Active: 2014
Title: Przemyslaw Zawadzki: Innovator in CB2 Receptor Modulation
Introduction
Przemyslaw Zawadzki is a notable inventor based in Skawina, Poland. He has made significant contributions to the field of pharmacology, particularly in the modulation of the CB2 receptor. His work focuses on developing compounds that can effectively treat inflammation and pain.
Latest Patents
Zawadzki holds a patent for "Compounds which selectively modulate the CB2 receptor." This patent describes compounds of formula (I) that bind to the CB2 receptor, acting as agonists, antagonists, or inverse agonists. These compounds are particularly useful in treating inflammation, with agonists also providing relief for pain. He has 1 patent to his name.
Career Highlights
Przemyslaw Zawadzki is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves research and development in the area of cannabinoid receptor modulation, contributing to innovative therapeutic solutions.
Collaborations
Zawadzki has collaborated with esteemed colleagues, including Alessandra Bartolozzi and Eugene R Hickey. These partnerships enhance the research efforts and broaden the scope of their work in the pharmaceutical industry.
Conclusion
Przemyslaw Zawadzki is a prominent figure in the field of cannabinoid research, with a focus on developing compounds that can effectively modulate the CB2 receptor. His contributions are paving the way for new treatments for inflammation and pain.